Andrew Williams

1

Article

1

Comment
An illustration of amyloid plaques within the human brain, characteristic features of Alzheimer’s. By 2060, approximately 14 million Americans are expected to have the disease. Kateryna Kon/Science Photo Library via Getty Images

The FDA approved a new drug to treat Alzheimer’s, but Medicare won’t always pay for it – a doctor explains what researchers know about Biogen’s Aduhelm

Andrew Williams, Albert Einstein College of Medicine

Although Medicare has agreed to pay for Aduhelm, its coverage comes with restrictions.

Contact Andrew for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision